Home › Resources › Medical Device Industry News

Medical Device Industry News

  • Goldman Sachs Invests $20 Million in India-Based BPL Medical

    Goldman Sachs (New York, NY) is one of the latest financial companies to make a significant investment in India. The multinational investment banked invested $20 million in a medical device company named BPL Medical Technologies. Funds will be used for expansion and commercialization of its technologies.

  • MIT Researcher Robert Langer Wins MDEA Lifetime Achievement Award

    MIT professor Robert Langer, PhD is the recipient of the third Lifetime Achievement Award associated with the Medical Design Excellence Awards (MDEA). The award will be presented in a ceremony at MD&M East in Philadelphia. The first MDEA Lifetime Achievement Winner was Alfred E. Mann, CEO of MannKind Corp. The second was Fogarty catheter inventor Thomas Fogarty, MD.

  • Hansen Shares Drop 20% Following Lackluster Q1

    Hansen Medical (Mountain View, CA) released a lackluster earnings report for the first quarter. Shares of the company have dropped almost 20% following yesterday’s release. In total, the company posted losses of $17.2 million. Sales for the first quarter were $3 million. This represents a 36.6% drop in sales and a 45.5% increase in losses over the first quarter of 2012.

  • Implants by Now-Defunct PIP Still Carry a Risk

    Last year, a report by top health regulators in the United Kingdom concluded that substandard breast implants by Poly Implant Prothèse didn’t pose a long-term health risk for patients. While the implants were at a higher risk of rupture than normal breast implants, health regulators originally stated that the implants weren’t harmful to women.

  • St. Jude: Durata Leads 100% Safe According to Independent Analysis

    St. Jude Medical (St. Paul, MN) has been under the watchful eye of the FDA for its Durata ICD leads. While these leads have been well-scrutinized, a new independent analysis shows that these defibrillator leads are 100 percent safe from mechanical failure and abrasion after five years. St. Jude Medical hopes that the latest results will help the company remain competitive.

  • Boston Scientific Releases Positive Watchman Results

    Boston Scientific (Natick, MA) released positive results for a clinical study of its Watchman medical device. Watchman is an implant that reduces the risk of strokes in patients suffering from atrial fibrillation.

  • CareFusion Hit by Third-Quarter Revenue Decline

    CareFusion (San Diego, CA) reported a decrease in revenue for the third quarter. In total, sales at the company declined two percent to $901 million. In part, this revenue decrease was due to declining demand for the company’s respiratory devices and dispensing technologies.

  • FDA Clears Novel Tactical Device for Hemorrhage Control

    FDA has cleared a novel device for treating unmanageable amputations and pelvic wounds. Developed by Combat Medical Systems (Fayetteville, NC), the device is a clamp developed for use by medics in the battlefield. The vise-like device can be used to eliminate the need for manual pressure to stop bleeding, freeing medics' hands to attend to other injuries.

  • FDA Clears Novel Tactical Device for Hemorrhage Control

  • Sony Invests in Israel-Based Rainbow Medical

    Sony (Tokyo, Japan) has invested $10 million in Rainbow Medical. Rainbow medical is an Israeli-based medtech incubator. Rainbow Medical manages its business operations in a way that is different from other financial groups. By licensing its own intellectual property to seed companies, Rainbow is able to maintain majority holdings in each of its investments. This allows it to steer the development of new companies.

Latest News

More News

Latest Resources

More Resources